TARO — Taro Pharmaceutical Industries Share News
0.000.00%
HealthcareBalancedMid Cap
- $1.62bn
- $735.77m
- $629.18m
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Brief: Taro Reports Qtrly Diluted Earnings Per Share Of $0.73
Taro Pharmaceutical Industries Ltd expected to post earnings of 88 cents a share - Earnings Preview
Taro Pharmaceutical Industries Ltd expected to post earnings of 88 cents a share - Earnings Preview
Senator Elizabeth Warren urges U.S. Justice Dept to aggressively fight price-fixing
Key Japanese ruling party official Kono hopes for March easing of border curbs (updated)
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Taro Pharmaceutical Industries Quarterly EPS $0.70
Taro Pharmaceutical Industries Ltd expected to post earnings of 91 cents a share - Earnings Preview
Taro Pharmaceutical Industries Ltd expected to post earnings of 91 cents a share - Earnings Preview
Brief: Taro Appoints New Chief Financial Officer
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in September - Earnings Summary
Brief: Taro Pharmaceutical Industries Reports Qtrly Sales Of $132 Million
Taro Pharmaceutical Industries Ltd expected to post earnings of $1.02 a share - Earnings Preview
Taro Pharmaceutical Industries Ltd expected to post earnings of $1.02 a share - Earnings Preview
Brief: Taro Reports Qtrly Loss Per Share $0.50
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in June - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 84 cents a share - Earnings Preview
Brief: Taro Announces Resignation Of Chief Financial Officer